Search

everythinglearnresearchcommunity

for

Search:↓

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Acitretin helped improve hand mobility and skin condition in a patient.

A patient with a rare disease had a unique genetic mutation linked to their symptoms.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

A patient with hair loss condition grew excessive hair in areas covered by a cast.

Modified PRP therapy successfully treated severe alopecia unresponsive to traditional methods.

A patient with a rare scalp condition showed improvement with isotretinoin and other medications.

A patient experienced permanent hair loss due to an allergic reaction to a corticosteroid injection.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

A patient with a severe scalp burn developed chronic bone infection, treated with surgery and muscle-skin flap from the back.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

A patient with lupus experienced a condition where their immune cells became overactive.

A patient with Ehlers-Danlos Syndrome improved after treatment for fat malabsorption and essential fatty acid deficiency.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

A patient with a rare hair condition and skin disorder showed hair improvement after treatment.

The document's conclusion cannot be determined from the provided text.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.

A patient with Myotonic dystrophy type 1 had multiple tongue hemangiomas and was sensitive to anesthesia.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Patients were very satisfied with the multidisciplinary group visit for alopecia areata.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.